Article Natassia F. Brenman; Richard Milne (May 2022)
“Ready for What?”: Timing and Speculation in Alzheimer’s Disease Drug Development. Science, Technology and Human Values (pp. 597-622). (/isis/citation/CBB016946522/) unapi

Article Margaret E. MacDonald (March 2021)
Misoprostol: The Social Life of a Life-saving Drug in Global Maternal Health. Science, Technology and Human Values (pp. 376-401). (/isis/citation/CBB680292467/) unapi

Book Danielle Giffort (2020)
Acid Revival: The Psychedelic Renaissance and the Quest for Medical Legitimacy. (/isis/citation/CBB791340763/) unapi

Article Matthew DeCloedt (2019)
Human Rights Litigation and the Medicalization of Cannabis in Canada, ca. 2000–Present. Pharmacy in History (pp. 59-77). (/isis/citation/CBB308654811/) unapi

Article Danya Glabau (2017)
Conflicting Assumptions: The Meaning of Price in the Pharmaceutical Economy. Science as Culture (pp. 455-467). (/isis/citation/CBB838843938/) unapi

Article Jane Bjørn Vedel; Alan Irwin (June 2017)
‘This is what we got, what would you like?’: Aligning and unaligning academic-industry relations. Social Studies of Science (pp. 417-438). (/isis/citation/CBB830128789/) unapi

Book Susan Craddock (2017)
Compound Solutions: Pharmaceutical Alternatives for Global Health. (/isis/citation/CBB833326907/) unapi

Article Enrico Cevolani (2016)
Un futuro per la canapa? Dall'alimentazione all'industria, il potenziale trascurato di una pianta straordinaria. Atti e Memorie, Rivista di Storia della Farmacia (pp. 40-49). (/isis/citation/CBB591727814/) unapi

Article Javier Lezaun; Catherine M. Montgomery (2015)
The Pharmaceutical Commons Sharing and Exclusion in Global Health Drug Development. Science, Technology and Human Values (pp. 3-29). (/isis/citation/CBB301150395/) unapi

Article Hedgecoe, Adam (2014)
A Deviation from Standard Design? Clinical Trials, Research Ethics Committees, and the Regulatory Co-Construction of Organizational Deviance. Social Studies of Science (pp. 59-81). (/isis/citation/CBB001421167/) unapi

Thesis Fidler, Bradley Reuben (2011)
Economies of Everyday Suffering: Some Implications of Eli Lilly's Zyprexa Market Strategy in US Primary Care. (/isis/citation/CBB001567336/) unapi

Article Bragesjö, Fredrik; Hallberg, Margareta (2011)
Dilemmas of a Vitalizing Vaccine Market: Lessons from the MMR Vaccine/Autism Debate. Science in Context (p. 107). (/isis/citation/CBB001034622/) unapi